Viral genotypes as determinants of autoimmune expression in chronic hepatitis C

Mayo Clinic Proceedings

Volumn 74, Issue 5, 1999, Pages 454-460

  Zein, Nizar N ^a   Persing, David H ^b   Czaja, Albert J ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CHRONIC HEPATITIS; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; REMISSION; VIRUS STRAIN;

EID: 0032916311     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/74.5.454     Document Type: Article

References (53)

1. Pateron D, Hartmann DJ, Duclos-Vallee JC, Jouanolle H, Beaugrand M. Latent autoimmune thyroid disease in patients with chronic HCV hepatitis [letter]. J Hepatol 1992;16:244-245
2. Tran A, Quaranta JF, Benzaken S, Thiers V, Chau HT, Hastier P, et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before Interferon therapy. Hepatology 1993;18:253-257
3. Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L, RoudotThoraval F, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994:19:841-848
4. Marcellin P, Pouteau M, Benhamou JP. Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction. J Hepatol 1995; 22:364-369
5. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N EnglJ Med 1993;328:465-470
6. Carson CW, Conn DL, Czaja AJ, Wright TL, Brecher ME. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993;20:304-309
7. Sansonno D, Cornacchiulo V, lacobelli AR, Di Stefane R, Lospalluti M, Dammacco F. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology 1995;21:305-312
8. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D, et al. Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339:321-323
9. Casato M, Taliani G, Pucillo LP, Goffredo F, Lagana B, Bonomo L. Cryoglobulinaemia and hepatitis C virus [letter]. Lancet 1991;337: 1047-1048
10. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage [published erratum appears in Gastroenterology 1995;108:620]. Gastroenterology 1994;106:1291-1300
11. Misiani R, Bellavita P, Fenili D, Vicari 0, Marches! D, Sironi PL, et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N EnglJ Med 1994;330:751-756
12. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Taswell HF, Homburger HA. Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States. J Hepatol 1993:18:342-352
13. Abuaf N, Lunel F, Giral P, Borotto E, Laperche S, Poupon R, et al. Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol 1993;18:359-364
14. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Immunologie features and HLA associations in chronic viral hepatitis. Gastroenterology 1995;108:157-164
15. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995;21:613-619
16. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis. J Hepatol 1996;24:52-59
17. Czaja AJ. Extrahepatic immunologie features of chronic viral hepatitis. Dig Dis 1997;15:125-144
18. Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983:2:1115-1119
19. Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest 1991:88:1370-1378
20. Mishiro S, Hoshi Y, Takeda K, Yoshikawa A, Gotanda T, Takahashi K, et al. Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process [published erratum appears in Lancet 1990;337:252]. Lancet 1990:336:1400-1403
21. Koskinas J, McFarlane BM, Nouri-Aria KT, Tibbs CJ, Mizokami M, Donaldson PT, et al. Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C. Gastroenterology 1994;107:1436-1442
22. Gonzalez-Peralta RP, Davis GL, Lau JYN. Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection. J Hepatol 1994;21:255-259
23. Mosnier JF, Scoazec JY, Marcellin P, Degott C, Benhamou JP, Feldmann G. Expression of cytokine-dependent immune adhesion molecules by hepatocytes and bile duct cells in chronic hepatitis C. Gastroenterology 1994 ; 107:1457-1468
24. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 1991:14:381-388
25. Simmonds P, Albert! A, Alter HJ, Bonino F, Bradley DW, Brechet C, et al. A proposed system for the nomenclature of hepatitis C viral genotypes [letter]. Hepatology 1994:19:1321-1324
26. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, et al. Hepatitis C virus genotypes: an investigation of typespecific differences in geographic origin and disease. Hepatology 1994:19:13-18
27. Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH (Collaborative Study Group). Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Ann Intern Med 1996:125:634-639
28. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C (Collaborative Study Group). Hepatitis C virus type Ib (II) infection in France and Italy. Ann Intern Med 1995:122:161-168
29. Zein NN, Rakela J, Poterucha JJ, Steers JL, Wiesner RH, Persing DH. Hepatitis C genotypes in liver transplant recipients: distribution and 1year follow-up. Liver Transpl Surg 1995:1:354-357
30. Nagayama R, Tsuda F, Okamoto H, Wang Y, Mitsui T, Tanaka T, et al. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein. J Clin Invest 1993:92:1529-1533
31. Alonso C, Qu D, Lamelin JP, de Sanjose S, Vitvitski L, Li J, et al. Serological responses to different genotypes of hepatitis C virus in France. J Clin Microbiol 1994;32:211-212
32. Zein NN, Rakela J, Persing DH. Genotype-dependent serologic reactivities in patients infected with hepatitis C virus in the United States. Mayo Clin Proc 1995:70:449-452
33. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Significance of human leukocyte antigens DR3 and DR4 in chronic viral hepatitis. Dig Dis Sei 1995:40:2098-2106
34. Donaldson P, Doherty D, Underhill J, Williams R. The molecular genetics of autoimmune liver disease. Hepatology 1994:20:225-239
35. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia MB, Andre C, et al. Extrahepatic immunologie manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995:122:169-173
36. Zignego AL, Ferri C, Giannini C, Monti M, La Civita L, Careccia G, et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996;124:31-34
37. Czaja AJ, Nishioka M, Morshed SA, Hachiya T. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastmenterology 1994;107:200-207
38. Czaja AJ, Cassani F, Cataleta M, Valentin! P, Blanchi FB. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 1996;24:1068-1073
39. Michitaka K, Durazzo M, Tillmann HL, Walker D, Philipp T, Manns MP. Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2. Gastmenterology 1994;106:1603-1610
40. Gerotto M, Pontisso P, Giostra F, Francesconi R, Muratori L, Ballardini G, et al. Analysis of the hepatitis C virus genome in patients with anti-LKM-1 autoantibodies. J Hepatol 1994;21:273-276
41. Czaja AJ, dos Santos RM, Porto A, Santrach PJ, Moore SB. Immune phenotype of chronic liver disease. Dig Dis Sci 1998;43:2149-2155
42. Doherty DG, Donaldson PT, Underhill JA, Farrant JM, Duthie A, MieliVergani G, et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology 1994:19:609-615
43. Czaja AJ. Autoimmune hepatitis and viral infection. Gastroenterol Clin Wo/trt Am 1994 Sep;23:547-566
44. Vento S, Di Perri G, Garofano T, Cosco L, Concia E, Ferraro T, et al. Hazards of Interferon therapy for HBV-seronegative chronic hepatitis [letter]. Lancet 1989:2:926
45. Papo T, Marcellin P, Bernuau J, Durand F, Poynard T, Benhamou JP. Autoimmune chronic hepatitis exacerbated by alpha-interferon. Ann Intern Med 1992:116:51-53
46. Shindo M, Di Bisceglie AM, Hoofnagle JH. Acute exacerbation of liver disease during Interferon alfa therapy for chronic hepatitis C. Gastmenterology 1992:102:1406-1408
47. Farhat BA, Johnson PJ, Williams R. Hazards of Interferon treatment in patients with autoimmune chronic active hepatitis [letter]. J Hepatol 1994:20:560-561
48. Garcia-Buey L, Garcia-Monzon C, Rodriguez S, Borque MJ, GarciaSanchez A, Iglesias R, et al. Latent autoimmune hepatitis triggered during Interferon therapy in patients with chronic hepatitis C. Gastmenterology 1995:108:1770-1777
49. Magrin S, Craxi A, Fabiano C, Simonetti RG, Fiorentino G, Marino L, et al. Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment. Hepatology 1994; 19:273-279
50. Czaja AJ, Carpenter HA. Histological findings in chronic hepatitis C with autoimmune features. Hepatology 1997:26:459-466
51. Homberg JC, Abuaf N, Bernard 0, Islam S, Alvarez F, Khalil SH, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology 1987:7:1333-1339
52. Nepom BS, Schwarz D, Palmer JP, Nepom GT. Transcomplementation of HLA genes in IDDM: HLA-DQ alpha- and beta-chains produce hybrid molecules in DR3/4 heterozygotes. Diabetes 1987:36:114-117
53. Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987;329:599-604